Zelira Therapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zelira Therapeutics Ltd with three other
companies in this sector in AUSTRALIA :
Amplia Therapeutics Ltd
sales of 1.53 million Australian Dollars [US$1.11 million]
(2.11 million Australian Dollars [US$1.53 million]
(2.33 million Australian Dollars [US$1.69 million]
of which 100%
was Drug Development).
Zelira Therapeutics Ltd reported sales of A$2.09 million (US$1.52 million)
June of 2021.
increase of 101.1%
versus 2020, when the company's sales were A$1.04 million.
Sales at Zelira Therapeutics Ltd have increased during each of the previous five years
(and since 2016, sales have increased a total of 76,544%).